Fikriye Eren

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Despite having the second highest mortality associated with cancer, currently Sorafenib is the only FDA-approved chemotherapeutic agent available for liver cancer patients which can only improve survival for few months. In this study, various pyrazolic chalcone analogous compounds were synthesized and evaluated as potential chemotherapeutic agents for the(More)
  • 1